Tafamidis
Drug ingredientCAS 594839-88-0
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293499 · basket
These shares come from HS customs code 293499, which covers 575 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Finland
- Netherlands
- Canada
- Indonesia
- Mexico
- Taiwan
- South Korea
- Austria
- Croatia
- Sweden
- Ukraine
- Denmark
- Israel
- Czech Republic
- New Zealand
- Hong Kong
- Kyrgyzstan
- Australia
- Portugal
- South Africa
- Poland
- Slovenia
- Brazil
- Slovakia
- Vietnam
- Latvia
- Malta
- Hungary
- Romania
- Kenya
- Belarus
- Russia
- Turkey
- Norway
12 FDA-registered drug labelers
Why It Matters
Appears in 1 drug and cosmetic product listings (FDA).
- •Vyndamax
- to be discontinued
Tafamidis Meglumine Capsule
Shortage listed since September 29, 2025
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
19 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| A2B Chem LLC | United States | $30.00 | 25 g | 98% |
| Angene Chemical | China → Hong Kong | $31.60 | 25 g | 98% |
| BLD Pharmatech Ltd. | China | $31.68 | 100 g | 98% |
| AA BLOCKS | United States | $33.40 | 25 g | 98% |
| Ambeed, Inc. | United States | $34.85 | 100 g | 98% |
| BLD Pharmatech Co., Limited | United States | $42.24 | 25 g | 98% |
| BLD Pharmatech GmbH | Germany | $42.24 | 25 g | 98% |
| Combi-Blocks, Inc. | United States | $42.24 | 25 g | 98% |
| AstaTech, Inc | United States | $95.60 | 5 g | 98% |
| Angene International Limited | United States | $329.00 | 1 g | 98% |
| MedKoo Biosciences, Inc | United States | $1975.00 | 2 g | 98% |
| Angene | China → Hong Kong | $2500.00 | 30 mg | 98% |
| Molnova | China | $3320.00 | 100 mg | 99% |
| TargetMol Chemicals | China → United States | $3690.00 | 100 mg | 99.65% |
| MedChemExpress MCE | Sweden | $6183.10 | 100 mg | 99.89% |
| Axon Medchem | Netherlands | $6480.00 | 50 mg | 99% |
| Cayman Europe | Estonia | $12566.40 | 50 mg | 98% |
| AK Scientific Specialized | United States | $17000.00 | 5 mg | 95% |
| AK Scientific, Inc. | United States | $23200.00 | 5 mg | 98% |
Chemical Identity
Data Sources
- PubChem · compound 11001318Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Tafamidis (CAS 594839-88-0) https://chemicalindependence.com/chemical/594839-88-0/ PubChem: 11001318. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11001318 FDA National Drug Code directory: CAS 594839-88-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 594839-88-0. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293499 for CAS 594839-88-0. Reporting year: 2024. https://usatrade.census.gov/